We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
EUG-FLUCLOXACILLIN (Eugia Pharma (Australia) Pty Ltd)
Product name
EUG-FLUCLOXACILLIN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
128 (175 working days)
Active ingredients
flucloxacillin, flucloxacillin sodium monohydrate
Registration type
New generic medicine
Indication
Treatment of confirmed or suspected staphylococcal infections and other Gram-positive coccal infections including pneumonia, skin and skin structure and wound infections, infected burns and cellulitis.